Skip to content

Frequency of Fibromyalgia in Behcet Disease

Frequency of Fibromyalgia in Behcet Disease in Province Bursa

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03514056
Enrollment
146
Registered
2018-05-02
Start date
2018-05-30
Completion date
2019-02-28
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behcet Syndrome, Fibromyalgia

Keywords

Fibromyalgia, Behcet Disease, Trigger points

Brief summary

In various studies, the incidence of fibromyalgia in Behçet's patients is widely distributed. It was aimed to investigate the frequency and severity of fibromyalgia in Behcet disease in province Bursa.

Detailed description

There are few studies in the literature investigating the frequency of fibromyalgia in Behçet's disease. In various studies, the incidence of fibromyalgia in Behçet's disease was 5.7% -37.1%, which is widely distributed. There are no studies in literature comparing disease severity and pain thresholds at trigger points in fibromyalgia with and without Behcet's disease. In this study, it was aimed to investigate the frequency of fibromyalgia in Behcet's disease according to the criteria defined by the American Colloge of Rheuatology in 2010 and updated in 2013. It was also aimed to compare the severity of disease in fibromyalgia with and without Behcet's disease.

Interventions

DIAGNOSTIC_TESTgroup 1:Patients diagnosed with Behcet disease

Frequency and severity of fibromyalgia will be investigated in patient diagnosed with Behcet disease

DIAGNOSTIC_TESTgroup 2: Patient diagnosed with fibromyalgia without Behcet disease

Severity of fibromyalgia will be investigated in patient diagnosed with fibromyalgia

Sponsors

Bursa Yuksek Ihtisas Training and Research Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with Behcet disease according to international study group criteria * Patients diagnosed with fibromyalgia according to classification criteria that were defined by the American Collage of Rheumatology in 2010 and updated in 2013 * Patients older than 18 * Patients younger than 75

Exclusion criteria

* Participants which were previously diagnosed with diabetes mellitus * Participants which were previously diagnosed with chronic renal failure * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
fibromyalgia 2013 criteriaSix monthsFibromyalgia 2013 criteria were derived from the 10-item symptom score from the Symptom Impact Questionnaire (SIQR) symptoms and the 28-area pain location inventory (PLI). If the patients PLI score is above 17 (range 0-28) and an SIQR symptom score is above 21 (range 0-50), the participant will be diagnosed with fibromyalgia

Secondary

MeasureTime frameDescription
Fibromyalgia impact questionnaireSix daysThe fibromyalgia impact questionnaire (FIQ) has 21 individual questions . All questions are based on an 11-point numeric rating scale of 0 to 10, with 10 being 'worst'. In the FIQ, all questions are framed in the context of the past 7 days. The total maximal score of the FIQ is 100.
Pain thresholdsSix monthsPain thresholds will be recorded by applying pressure to the 28 sensitive points until the participants demonstrate pain. Manual algometry device will be used to measure the pain threshold.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026